XPRIZE and the Musk Foundation Award $15M to Prize Milestone Winners in $100M Carbon Removal Competition
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Milestone Round. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
A team from the University of Toronto’s Faculty of Applied Science & Engineering has placed among the top 60 in the Milestone Round of the global XPRIZE Carbon Removal competition.
Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public Compass Pathways (NASDAQ:CMPS) and MindMed (NASDAQ:MNMD) remain the only two companies in psychedelics to reach a major U.S. stock exchange. Both companies presented net losses associated with R&D expenses, as entities in the space race towards gaining ground in a sector that still hasn’t reached early maturity or profitability. Both companies presented strong cash positions to advance their research pipelines. Compass, Pressing On Psilocybin: Compass highlighted the issuing of two new ...
This week, Health Canada opened a public consultation on its “proposal to restore potential access to restricted drugs through the Special Access Program (SAP).” The SAP allows healthcare professionals to request unapproved drugs for patients with serious or life-threatening conditions if other therapies have failed, aren’t suitable or are not available in Canada. The proposal includes bringing MDMA and psilocybin back from a 2013 amendment to the Food and Drug Regulations that restricted these drugs, among others, to be part of the SAP. If the once restricted drugs qualify again for t...